Table 2.
Characteristics of identified studies in this meta-analysis
| Study | Newborns | HBV+ newborns | Mothers | Infants | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | Year | Area | design | Caesarean | Vaginal | Caesarean | Vaginal | HBeAg + (%) | Intervention | HBIG | Vaccine | Follow-up |
| Wang Qingtu | 2001 | Shandong | RC | 38 | 84 | 4 | 28 | 100 | NR | NR | NR | 1 h |
| Wang Jianshe | 2002 | Shanghai | RC | 117 | 184 | 13 | 17 | 36.54 | NR | 100% | 1, 2 and 7 months | 12 months |
| Wang Lan | 2004 | Shandong | RC | 61 | 183 | 11 | 61 | 100 | NR | 75.82% | 0, 1 and 6 months | 1 month |
| Wang Yuan | 2005 | Jiangsu | RC | 58 | 42 | 1 | 0 | 22 | 100% HBIG | 100% | 0, 1 and 6 months | 2 month |
| Gu Jie | 2006 | Ningxia | RC | 64 | 85 | 2 | 5 | 34.9 | No | 100% | 0, 1 and 6 months | 12 months |
| Qian Yanhua | 2006 | Jiangsu | RC | 26 | 24 | 0 | 2 | NR | 80% HBIG | 80% | 0, 1 and 6 months | 12 months |
| Fan Yi | 2007 | Guangdong | RC | 92 | 103 | 2 | 9 | 4.1 | NR | 100% | 0, 1 and 6 months | 6 months |
| Chen Jing1 | 2007 | Tianjin | RC | 176 | 53 | 27 | 13 | 100 | NR | NR | NR | 1 h |
| Chen Jing2 | 2007 | Tianjin | RC | 112 | 68 | 3 | 10 | 0 | NR | NR | NR | 1 h |
| Li Jijun1 | 2007 | Gansu, Jiangsu | RC | 12 | 49 | 4 | 19 | 100 | NR | NR | 0, 1 and 6 months | 3–9 years |
| Li Jijun2 | 2007 | Gansu, Jiangsu | RC | 74 | 184 | 5 | 28 | 0 | NR | NR | 0, 1 and 6 months | 3–9 years |
| Chen Hong | 2008 | Beijing | RC | 112 | 180 | 4 | 5 | 4.45 | No | NR | 0, 1 and 6 months | 6 months |
| Liu Xia | 2008 | Tianjin | RC | 153 | 54 | 14 | 15 | NR | NR | NR | NR | 2 h |
| Liu Honge | 2009 | Guangdong | RC | 86 | 123 | 2 | 9 | 3.83 | NR | 100% | 0, 1 and 6 months | 1 month |
| Zhang Qingying | 2009 | Shanghai | RC | 166 | 52 | 1 | 7 | NR | No | 100% | 0, 1 and 6 months | 6 months |
| Zhu Yunxia | 2010 | Beijing | RC | 114 | 102 | 5 | 6 | 100 | No | 100% | 0, 1 and 6 months | 7 months |
| Yang Peifang | 2010 | Shanghai | RC | 32 | 36 | 0 | 1 | 19.1 | No | 100% | 0, 1 and 6 months | 12 months |
| Yang Xiaomei | 2011 | Guangdong | RC | 33 | 49 | 4 | 7 | NR | NR | 100% | 0, 1 and 6 months | 6 months |
| Zhang Weili | 2011 | Shanghai | RC | 508 | 127 | 17 | 5 | NR | NR | 100% | 0, 1 and 6 months | 3 months |
| Huang Liu | 2012 | Guangdong | RC | 122 | 168 | 9 | 17 | NR | NR | NR | NR | 24 h |
| Guo Zhen | 2013 | Shanxi | CC | 584 | 549 | 29 | 72 | 36.19 | NR | NR | NR | 24 h |
| Wang Ling | 2013 | Sichuan | RC | 112 | 148 | 7 | 16 | NR | 100% HBIG | 100% | 0, 1 and 6 months | 6 months |
| Hu Yali | 2013 | Jiangsu | RC | 285 | 261 | 7 | 6 | 24.73 | NR | 53.30% | 0, 1 and 6 months | 5–7 years |
| Yin Yuzhu | 2013 | Guangdong | RC | 692 | 668 | 12 | 9 | 34.76 | 39.70% HBIG | 100% | 0, 1 and 6 months | 12 months |
| Pan Calvin Q. | 2013 | Beijing | RC | 496 | 673 | 7 | 23 | 54.5 | No | 100% | 0, 1 and 6 months | 7–12 months |
| Zhang Lei | 2014 | Multicenter | RC | 221 | 194 | 17 | 22 | 100 | 21.93% HBIG | 84.34% | 0, 1 and 6 months | 8-12 months |
| Wang Lina | 2014 | Guangdong | RC | 149 | 122 | 6 | 9 | 34.32 | No | 100% | 0, 1 and 6 months | 7–12 months |
| Li Weiru | 2014 | Guangdong | RC | 120 | 120 | 2 | 12 | NR | No | 100% | 0, 1 and 6 months | 6 months |
| Huang Dan | 2014 | Hubei | RC | 86 | 64 | 4 | 8 | 18.67 | No | 100% | 0, 1 and 6 months | 6 months |
| Liu Cuiping | 2015 | Sichuan | CC | 204 | 52 | 4 | 6 | 67.19 | 7.81% antiviral; 43.36% HBIG | 100% | 0, 1 and 6 months | 6–12 months and/or 1–3 years |